Ono Pharmaceutical Co Ltd - Common Stock - Foreign

Historical Holders from Q4 2015 to Q3 2025

Type / Class
Equity / Common Stock - Foreign
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
215,629
Holdings value
$2,483,120
% of all portfolios
0%
Number of holders
1
Number of buys
1
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Ono Pharmaceutical Co Ltd - Common Stock - Foreign

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 215,629 $2,483,120 +$97,538 $11.52 1
2025 Q2 207,159 $2,242,706 -$137,761 $10.83 1
2025 Q1 219,884 $2,349,251 -$249,173 $10.68 1
2024 Q4 243,206 $2,526,424 -$2,114,436 $10.39 1
2024 Q3 446,752 $5,941,669 -$32,252 $13.3 1
2024 Q2 449,177 $6,132,247 +$2,949,445 $13.65 1
2024 Q1 233,135 $3,814,740 +$508,752 $16.36 1
2023 Q4 202,043 $3,605,250 +$3,605,250 $17.84 1
2023 Q3 0 $0 -$2,293,305 0
2023 Q2 126,981 $2,293,305 +$2,226,663 $18.06 1
2023 Q1 3,690 $76,815 +$2,436 $20.82 1
2022 Q4 3,573 $83,934 +$83,934 $23.49 1
2021 Q1 0 $0 -$824,826 0
2020 Q4 27,400 $824,826 $30.1 1
2020 Q3 27,400 $857,857 +$65,748 $31.31 1
2020 Q2 25,300 $735,655 $29.08 1
2020 Q1 25,300 $582,611 +$241,795 $23.03 1
2019 Q4 14,800 $340,737 $23.02 1
2019 Q3 14,800 $267,995 $18.11 1
2019 Q2 14,800 $265,394 $17.93 1
2019 Q1 14,800 $290,023 +$39,192 $19.6 1
2018 Q4 12,800 $261,915 $20.46 1
2018 Q3 12,800 $362,301 $28.3 1
2018 Q2 12,800 $300,109 $23.45 1
2018 Q1 12,800 $396,457 $30.97 1
2017 Q4 12,800 $298,383 $23.31 1
2017 Q3 12,800 $289,909 $22.65 1
2017 Q2 12,800 $279,217 $21.81 1
2017 Q1 12,800 $264,719 +$233,697 $20.68 1
2016 Q4 1,500 $32,865 $21.91 1
2016 Q3 1,500 $41,572 $27.71 1
2016 Q2 1,500 $64,802 $43.2 1
2016 Q1 1,500 $63,593 +$50,874 $42.4 1
2015 Q4 300 $54,092 +$54,092 $180.31 1